NEW YORK (GenomeWeb News) – Private equity firm GTCR today announced a partnership with former Gen-Probe executives Carl Hull and Eric Tardif to form Maravai Life Sciences.

Based in San Diego, Maravai will acquire diagnostics and life science companies and products "as part of a strategy to build a market-leading healthcare business," GTCR said, adding it is investing up to $300 million into the partnership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.